SILO PHARMA, INC.
560 Sylvan Avenue, Suite 3160
Englewood Cliffs, NJ 07632
April 8, 2021 |
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Sisi Cheng
Re: | Silo Pharma, Inc. |
Registration Statement on Form S-1 | |
Filed April 7, 2021 | |
File No. 333-253170 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Silo Pharma, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Monday April 12, 2021, or as soon thereafter as possible.
Please notify Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 653-8179 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
SILO PHARMA, INC. | ||
By: | /s/ Eric Weisblum | |
Name: | Eric Weisblum | |
Title: | Chief Executive Officer |